Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Fortress Biotech's Mustang Bio closes private placement financing to support immunotherapy pipeline

Feb. 3, 2017

Protagen and NCI collaborate to provide insight into immuno-oncology

Feb. 3, 2017

FDA grants accelerated approval to Opdivo in metastatic urothelial carcinoma

Feb. 3, 2017

FDA orphan drug status given to CyTIX-DCf 12-GLI for malignant glioma

Feb. 3, 2017

Regen Biopharma enters agreement to optimize NR2F6 modulators

Feb. 3, 2017

Targovax reports survival data from first cohort of phase I/II study of TG-01 in pancreatic cancer

Feb. 2, 2017

Keytruda approved for first-line treatment of metastatic NSCLC in E.U.

Feb. 1, 2017

Results from phase Ib trial of AM-0010 plus FOLFOX in metastatic pancreatic adenocarcinoma

Jan. 30, 2017

Scancell and Addario Lung Cancer Medical Institute collaborate on trials of SCIB-2

Jan. 30, 2017

GreenPeptide initiates phase II trial of GRN-1201 for NSCLC in U.S.

Jan. 30, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...